In July 2020 PharmaVision Europe launched as first-to-market generic the brand TravoVis Combo eye drops. The product is subject to medical prescription and is used for treatment of glaucoma. The fixed combination contains travoprost (40mcg/ml) and timolol (5mg/ml).
News from Pharma Vision
- Launch of TravoVis Combo (travoprost+timolol) eye drops on key markets in Western Balkans.
- PharmaVision Europe qualified for funding from Operational Programme “Innovations and competitiveness”, Priority Axis “Entrepreneurship and Capacity for growth of SMEs”, procedure ” Support for micro and small enterprises for overcoming the shortage of funding and the lack of liquidity caused by the epidemic outbreak of COVID-19″
- Launch of full ophthalmic portfolio of PharmaVision Europe in Albania
- PharmaVision Europe ophthalmic line launch during the meeting the of the Association of Ophthalmologists in the Republic of Macedonia on 20 April 2018
- Launch of UROPROST tabl. x 60 – Patented Formula for Urinary Health